Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW 16,960
+200 (1.19%)
Apr 10, 2026, 3:30 PM KST
Genomictree Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -8,986 | -10,242 | -8,756 | -6,631 | -11,425 |
Depreciation & Amortization | 1,065 | 1,186 | 1,178 | 1,335 | 1,022 |
Loss (Gain) From Sale of Assets | 117.47 | 4.46 | - | -8.5 | -17.1 |
Asset Writedown & Restructuring Costs | 7.96 | - | - | - | - |
Loss (Gain) From Sale of Investments | 649.36 | -828.71 | 328.33 | 2,097 | 2,072 |
Stock-Based Compensation | 991.55 | 1,934 | 1,633 | 249.51 | 694.04 |
Provision & Write-off of Bad Debts | 45.94 | 45.94 | 188.53 | 2,064 | - |
Other Operating Activities | -2,545 | -2,937 | -3,909 | 7,075 | 764.11 |
Change in Accounts Receivable | -63.76 | 59.14 | -6,688 | -636.9 | -1,362 |
Change in Inventory | 83.08 | 199.85 | 54.74 | -303.82 | 1,000 |
Change in Accounts Payable | 10 | 0.1 | 3,501 | 154.42 | -728.24 |
Change in Unearned Revenue | 1 | 0.27 | -9.17 | -3 | 13.19 |
Change in Other Net Operating Assets | -1,569 | -3,055 | 1,597 | -1,106 | 335.58 |
Operating Cash Flow | -10,193 | -13,633 | -10,881 | 4,286 | -7,631 |
Capital Expenditures | -2,726 | -2,484 | -239.08 | -1,762 | -10,963 |
Sale of Property, Plant & Equipment | 42.67 | 1 | - | 21.36 | 52.89 |
Sale (Purchase) of Intangibles | -19.36 | -67.88 | -49.32 | -61.64 | -865.31 |
Investment in Securities | -393.68 | -11,941 | 5,522 | 13,459 | -41,774 |
Other Investing Activities | 3,111 | 3,004 | 2,885 | 2,412 | 4,478 |
Investing Cash Flow | 14.08 | -11,488 | 8,119 | 14,069 | -49,072 |
Long-Term Debt Issued | - | - | - | - | 50,191 |
Long-Term Debt Repaid | -49.91 | -49.91 | -54.3 | -14,534 | -2,242 |
Total Debt Repaid | -49.91 | -49.91 | -54.3 | -14,534 | -2,242 |
Net Debt Issued (Repaid) | -49.91 | -49.91 | -54.3 | -14,534 | 47,949 |
Issuance of Common Stock | 231.96 | - | - | - | 4,996 |
Repurchase of Common Stock | - | - | - | -4,984 | - |
Other Financing Activities | -0 | 6,072 | -20,443 | -6.21 | 0 |
Financing Cash Flow | 182.05 | 6,022 | -20,497 | -19,525 | 62,869 |
Foreign Exchange Rate Adjustments | -39.09 | 102 | 402.28 | 2,280 | 3,654 |
Net Cash Flow | -10,036 | -18,998 | -22,856 | 1,110 | 9,820 |
Free Cash Flow | -12,919 | -16,118 | -11,120 | 2,523 | -18,593 |
Free Cash Flow Margin | -343.58% | -682.29% | -325.32% | 8.45% | -361.76% |
Free Cash Flow Per Share | -537.70 | -675.09 | -419.50 | 120.20 | -900.62 |
Cash Interest Paid | - | - | - | - | 45.45 |
Cash Income Tax Paid | -40.4 | -129.05 | -73.91 | 2,096 | 473.01 |
Levered Free Cash Flow | -8,926 | -10,093 | -29,381 | 20,761 | -22,739 |
Unlevered Free Cash Flow | -8,715 | -9,909 | -28,097 | 24,125 | -19,860 |
Change in Working Capital | -1,539 | -2,795 | -1,544 | -1,895 | -741.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.